Endocrine Disruption: What Does the Future Hold for Safety Assessment?
|
|
- Donald Kennedy
- 6 years ago
- Views:
Transcription
1 RSA Conference 2017 Endocrine Disruption: What Does the Future Hold for Safety Assessment? 31 January 1 February 2017 Venue: Cranage Hall, Cheshire, UK Sponsored by:
2 RSA Conference 2017 Endocrine Disruption: What Does the Future Hold for Safety Assessment? January 31st February 1st 2017 Cranage Hall, Cheshire, UK Endocrine disruption (ED) is a hot topic on all agendas with draft EU criteria for EDs published in Both human and environmental safety assessment of agrochemicals, pharmaceuticals, chemicals and biocides require consideration of endocrine disrupting properties. The US and Europe regulate for such properties in different ways with risk based approaches in the US and hazard in the EU. To understand the mechanism(s) of action for ED, adverse outcome pathways can be very helpful and, with application of category approaches, animal testing may be minimized. This conference will explore the regulatory implications of ED assessment across the various areas of chemical use in different regions and how to make best use of the available tools for optimizing or avoiding unnecessary testing. In Memory of Charlotte Croudace An inspiration to RSA
3 Summary Timetable Day 1 (31st January 2017) Arrive 13:00 for coffee Day 2 (1 st February 2017) Start 09:00 Opening Remarks 13:45 by RSA Session 1 Regulatory implications of endocrine disruption (14:00-15:30) Chair: Dr Steve Fairhurst, UK Health and Safety Executive Prof Alan R Boobis OBE, Imperial College London Regulatory update and implications for human health. Risk vs hazard assessment. Prof Peter Matthiessen, Consultant Ecotoxicologist Environmental Hazard and Risk Assessment Approaches: Pellston Workshop output on ED assessment. Dr Christian Strupp, Adama Regulatory Context and Impact on (Agro)Chemicals. Panel discussion Break for coffee (15:30-16:15) Session 2 Assessing endocrine disruption for human health (16:15-17:45) Chair: Prof Ian Kimber OBE, University of Manchester Dr Richard Green, Dow AgroSciences Assessment and Application of Adverse Outcome Pathways Relevant to the Endocrine System. Dr Jenny Odum, RSA Use of the OECD Conceptual Framework in testing for and reviewing endocrine effects. Dr Malgorzata Nepelska, Unilever, UK AOP for PPARactivation in utero leading to impaired fertility in males. Implications for human health? Panel discussion Session 3 - Assessing endocrine disruption in the environment (09:00-10:30) Chair: Prof Peter Matthiessen, Consultant Ecotoxicologist Richard Murray-Smith, RSA Environmental risk assessment and endocrine disruption. Dr Lennart Weltje, BASF SE Masculinisation in wild fish and the possible involvement of azoles a reality check. Dr James Wheeler, Dow AgroSciences Ecotoxicology endocrine testing: current and future perspectives. Panel discussion Break for coffee (10:30-11:15) Session 4 Reducing animal testing for endocrine disruption (11:15-12:15) Chair: Prof Martin Wilks, Swiss Centre for Applied Human Toxicology, University of Basel Dr Stewart Owen, AstraZeneca Minimizing the use of fish in tests using MoA strategies. Prof Mark Cronin, Liverpool John Moores University Use of AOPs to reduce in vivo testing. Panel discussion Final discussion session with invited panellists (12:15-12:45) Chair: Prof Martin Wilks, Swiss Centre for Applied Human Toxicology, University of Basel 13:00 Close of the conference followed by lunch 19:00 Drinks reception followed by Conference Dinner. After Dinner Speaker: Prof Lewis Smith 2
4 Full Programme Day 1 (31st January 2017) Arrive 13:00 for coffee Opening Remarks 13:45 by RSA Session 1 Regulatory implications of endocrine disruption (14: ) Chair: Dr Steve Fairhurst, UK Health and Safety Executive Prof Alan R Boobis OBE, Imperial College London Regulatory update and implications for human health. Risk vs hazard assessment. Definition of an EDC What is the endocrine system Distinguishing between adverse and non-adverse effects Implications of move to non-animal test methods Critical importance of dose-response in addressing many of these issues Prof Peter Matthiessen, Consultant Ecotoxicologist Environmental Hazard and Risk Assessment Approaches: Pellston Workshop output on ED assessment. Hazard or risk assessment for environmental EDs? Case studies of 6 chemicals How environmental hazard and risk assessment of EDs should be carried out Dr Christian Strupp, Adama Regulatory Context and Impact on (Agro)Chemicals. The context: Science or conviction? Global regulatory approaches Do we have an issue and are we testing correctly? What we already have for agrochemicals Global trade Panel discussion Break for coffee (15:30-16:15) 3
5 Session 2 Assessing endocrine disruption for human health (16:15-17:45) Chair: Prof Ian Kimber OBE, University of Manchester Dr Richard Green, Dow AgroSciences Assessment and Application of Adverse Outcome Pathways Relevant to the Endocrine System. Overview of the current state of the science with respect to AOPs relevant to the endocrine system and how they are currently being developed and assessed Suggested key elements to be considered when evaluating the utility of these AOPs for different, defined purposes Consideration of how these AOPs may be used in the future e.g., identification of Endocrine Disruptors for regulatory purposes Dr Jenny Odum, RSA Use of the OECD Conceptual Framework in testing for and reviewing endocrine effects. The OECD Conceptual Framework, Guidance Document 150 and how they may be used Weight of evidence approaches Deciding on whether a substance is an ED Dr Malgorzata Nepelska, Unilever, UK AOP for PPAR activation in utero leading to impaired fertility in males. Implications for human health? AOP development process; rationale for choosing pathway Controversy around the pathway: OECD review outcome Examples of uses within regulatory context Panel discussion Conference Dinner Drinks reception sponsored by IEH Consulting 19:00 Dinner with drinks sponsored by JSC International 20:00 After Dinner Speaker: Prof Lewis Smith. 4
6 Day 2 (1 February 2017) Welcome Back Session 3 - Assessing endocrine disruption in the environment (09:00-10:30) Chair: Prof Peter Matthiessen, Independent Consultant Richard Murray-Smith, RSA Environmental risk assessment and endocrine disruption. What does ED mean for ERA? Why we need to demystify ED Why it s not all about NOEC s What s going to change in future ERA s Dr Lennart Weltje, BASF SE Masculinisation in wild fish and the possible involvement of azoles a reality check. Mechanisms and effects of azoles in the laboratory Field observations on masculinisation in wild fish populations Exploring causality and potential for effects Conclusions and implications for regulation Dr James Wheeler, Dow AgroSciences Ecotoxicology endocrine testing: current and future perspectives. Development of new tests in multiple taxa and species The need for better mechanistic understanding of endocrine and non-endocrine toxicities Weight-of-evidence Panel discussion Break for coffee (10:30-11:15) 5
7 Session 4 - Reducing animal testing for endocrine disruption (11:15-12:15) Chair: Prof Martin Wilks, Swiss Centre for Applied Human Toxicology, University of Basel Dr Stewart Owen, AstraZeneca - Minimizing the use of fish in tests using MoA strategies. Exclusion of other MOAs (e.g. cytotoxicity, mutagenicity,) Elucidation of rodent MOA in vivo: We have been working on science-based approaches to prioritise risks posed to the aquatic environment by legacy human pharmaceuticals. A cascade approach using knowledge of the properties and in silico and vitro screens could minimise testing in fish. We can separate endocrine disrupters from other modes of action based on a sensitivity analysis, and have developed a quantitative Adverse Outcome Pathway (qaop) for glucocorticoids that could have wider application in understanding the risks and guiding the testing strategy. Prof Mark Cronin, Liverpool John Moores University Use of AOPs to reduce in vivo testing. Review of current AOPs for endocrine disruption Contribution of AOPs to design in silico and in vitro assays for endocrine disruption Supporting read-across with in silico and in vitro data Integrating information from non-animal tests in an AOP framework to provide a weight of evidence to reduce in vivo testing Panel discussion Final discussion session with invited panellists (12:15-12:45) Chair Prof Martin Wilks, Swiss Centre for Applied Human Toxicology, University of Basel A panel drawn from the session speakers and chairs will discuss issues identified during the seminar. Close of meeting 13:00 by RSA Lunch sponsored by Envigo 6
8 RSA wish to thank the exhibitors and sponsors, CXR Biosciences, Cyprotex Discovery Ltd, JSC International, IEH Consulting, Scymaris, Envigo and Syngenta for their sponsorship of this event. 7
9 Speaker and Chair Biographies Dr Steve Fairhurst, Head of REACH, Classification & Labelling and environmental sciences provision, UK Health and Safety Executive, Bootle, Merseyside Steve has worked for the UK Health and Safety Executive (HSE), delivering and managing regulatory toxicology, since the mid-1980s. He is part of the senior management team of HSE s Chemicals Regulation Division (CRD), formed in 2009 to bring together in the UK the regulatory science and the operation of regulatory regimes for UK/EU legislation covering Plant Protection Products (pesticides), biocides and industrial chemicals. In this setting, Steve has senior management responsibility for the delivery of REACH and Classification & Labelling operations. Also, despite having Daphnia-sized credentials, he is the responsible senior manager for HSE s environmental science input to all the above pieces of legislation. Steve has chaired and served on a variety of UK and EU expert committees and groups concerned with chemical hazards and (primarily) occupational health risk considerations. He is also the current chair of the Interdepartmental Group on Health Risks from Chemicals (IGHRC) that operates to harmonise and progress regulatory toxicology across all relevant UK government departments. Since 2010, Steve has led HSE s scientific input into the long-running debate about the most appropriate means of identifying for regulatory purposes chemicals that possess endocrine-disrupting properties, working with a small team in which Susy Brescia has been particularly prominent. We re not finished yet! Prof Alan R Boobis OBE, Imperial College London Alan Boobis is Professor of Biochemical Pharmacology, Imperial College London. His research interests include mechanistic toxicology, risk assessment and food safety. He has published around 240 original research papers. He is a member/chair of several national and international advisory committees and currently chairs the UK Committee on Toxicity. He is chair of the Board of Trustees of the International Life Sciences Institute (ILSI). He has received several awards, including Officer of the British Empire (OBE). Prof Peter Matthiessen, Consultant Ecotoxicologist (independent) Peter Matthiessen has conducted research into the impacts of pollutants on aquatic life since Since the mid-1980s, he has become very involved with studies of endocrine disrupters such as ethynyl estradiol and tributyltin, and he is currently studying the effects of sewage discharges on the ability of fish to make normal corticosteroid responses to stress. He also has a strong advisory role, having just stepped down as a member of the Advisory Committee on Pesticides and joined the EFSA Working Group on Endocrine Disrupting Substances. Most relevantly for this session, Peter is co-chair of the OECD Validation Management Group for Ecotoxicity Tests, and is also a lead author (with Jenny Odum) of OECD guidance document 150 on how to interpret the results of tests with sensitivity to endocrine disrupters. 8
10 Dr Christian Strupp, Adama After completing studies in food chemistry, Christian Strupp moved to Novartis Pharma for thesis and handson work on oxidative stress and genetic knockdown models in toxicology. From there he took a position at RCC/Harlan for several years as a consultant in regulatory toxicology of (agro)chemicals and biocides, also completing the registration program as ERT. He is currently heading the Human Health Team of Adama Agriculture dealing globally with toxicology, metabolism, dietary and non-dietary risk assessment. Prof Ian Kimber OBE, University of Manchester Ian Kimber is currently Professor of Toxicology in the Faculty of Biology, Medicine and Health at the University of Manchester. He also served as Associate Dean for Business Development from He has broad research interests at the interface between toxicology and immunology, with a particular focus on allergy and inflammation. Professor Kimber holds, and has held, a variety of positions on national and international expert and scientific advisory committees. Currently these include the following: Member UK Medicines and Healthcare products Regulatory Agency (MHRA) Devices Expert Advisory Committee, Programme Advisor Food Standards Agency Food Allergy and Intolerance Research Programme, member Scientific Advisory Board National Institute for Biological Standards and Control, member MRC Translational Research Group, and Council member Laboratory Animal Science Association. Professor Kimber was previously: Deputy Chair of the MRC Physiological Medicine and Infection Board ( ), President of the British Toxicology Society ( ), and Chairman of the Board of the UK National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs) ( ). Professor Kimber has published over 535 peer-reviewed research papers and review articles, over 100 book chapters, and 6 books. He serves currently on the editorial boards of toxicology, immunology, dermatology and pathology journals. Professor Kimber has received a number of awards and prizes. These include: the SmithKline Beecham Laboratory Animal Welfare Prize (2000) (jointly with David Basketter and Frank Gerberick), the 9th Robert A Scala Award in Toxicology (2001), the Doerenkamp-Zbinden Foundation Prize for Realistic Animal Protection in Biomedical Research (2001), Society of Toxicology Enhancement of Animal Welfare Award (2003) (jointly with Frank Gerberick), and Society of Toxicology Immunotoxicology Career Achievement Award (2005). In 2010 Professor Kimber received the Eurotox Bo Holmstedt Memorial Fellowship Award and Lecture at the International Congress of Toxicology. In 2015 Professor Kimber received the Society of Toxicology Distinguished Toxicology Scholar Award. In 2015 he was awarded the Barnes Prize Lecture by the British Toxicology Society. Professor Kimber was elected to membership of Academia Europaea in In 2011 Professor Kimber was awarded an OBE in the Queen s Birthday Honours list for services to science. Dr Richard Green, Toxicologist and Risk Assessor, Dow AgroSciences Following completion of his PhD at the University of Birmingham, Richard has been working as a toxicologist in the crop protection industry; previously with Syngenta and currently with Dow AgroSciences. His areas of specialism include mechanistic toxicology and endocrine disruption. Currently he is chairing a European Centre for Ecotoxicology and Toxicology of Chemicals (ECETOC) task force developing guidance on assessment and application of adverse outcome pathways (AOPs) relevant to the endocrine system. 9
11 Dr Jenny Odum, Consultant Toxicologist, Regulatory Science Associates Jenny Odum has over 25 years experience as an industrial toxicologist and is currently a Consultant Toxicologist with Regulatory Science Associates. She has a broad range of expertise within toxicological specialities in both regulatory and research arenas and has published widely. She is an expert in the field of endocrine disruption, providing specialist advice on endocrine disruption testing and assessment in the field of human health and written position statements for compound defence. She is a member of a number of OECD expert panels on testing for endocrine disruption and the development of test guidelines. She has also co-authored a number of OECD guidance documents on tests for endocrine disrupters and reproductive toxicology. Dr.Małgorzata Lucyna Nepelska, Risk assessor /Novel approaches, Unilever, UK Dr. Nepelska is a Risk Assessor / Novel approaches at Unilever. Previously employed by the European Commission's Joint Research Centre (JRC) in Ispra/Italy as Scientific Project Officer. She specialized in scientific policy support for mode of action based assessment of endocrine disrupting chemicals with focus on AOP development. Dr. Nepelska is a researcher by nature and biotechnologist by training. She graduated from the Warsaw Agricultural University in the Interfaculty Studies of Biotechnology and obtained her PhD. degree in Physiology and pathophysiology from the University Pierre et Marie Curie in Paris. Currently, she is finalising a Postgraduate Toxicology course at the Vienna Medical University. She had her first hand-on laboratory experience abroad at the University of Natural Resources and Applied Life Sciences in Vienna. Next, at the Austrian Research Centres she performed the experimental part of her master thesis. Both of these experiences gave her applied knowledge of molecular biology, microbiology and immunology. Having obtained her MSc she continued to conduct research in the field of endocrinology/neurobiology. Between 2007 and 2008, she worked at the National Hellenic Research Foundation in Athens. Within this project she examined the neuroprotective properties of natural compounds and their mode of action. The next step in her career was an internship at the International Atomic Energy Agency s Laboratories in Seibersdorf/Austria. In this work she used genomics for the identification of new genetic markers for the susceptibility to pathogens. Her co-supervised PhD study took place in France and included an exchange period at the Karolinska Institutet in Sweden. In this project a pioneer high-throughput functional screening approach was applied for the identification of new bacterial molecules that are involved in the crosstalk with nuclear receptors regulating the key genes in human host physiology. Her work is guided by need to rationalize and help to make connections between ideas. Dr Nepelska`s research interest encompasses: development of alternative approaches in risk assessment with particular focus on AOPs, nuclear receptors and their role in response to xenobiotics and involvement of human microbiota in reaction to harmful compounds. 10
12 Prof Lewis Smith Lewis Smith is now retired but continues to act as a consultant on toxicology and governance issues. From 1971 to 1991, Lewis was responsible for a number of toxicological research projects in ICI and was ultimately Head of the Biochemical Toxicology Department in the Central Toxicology Laboratory (CTL). In 1991, Lewis left ICI to become Professor of Biochemical Toxicology at the University of Leicester and Director of both the Medical Research Council s Institute for Environment and Health and the MRC Toxicology Unit. Lewis has published approximately 100 articles, papers or book chapters on various aspects of the mechanism of toxicity of drugs, pesticides and industrial chemicals. In 1998, he returned as Director of Zeneca s CTL (previously ICI). After Zeneca merged with Astra in 1999, the biotech and agroscience businesses of AstraZeneca and Novartis were hived off and merged to form Syngenta. Lewis held several positions in Syngenta's head office in Basel including head of product development. He retired from Syngenta in Richard Murray-Smith, Consultant in Environmental Risk Assessment, Regulatory Science Associates Richard is a consultant ERA specialist working with Regulatory Science Associates. Richard worked for AstraZeneca (AZ), formerly ICI/Zeneca, for >20 years, initially in mathematical modelling, then as a project manager, environmental risk assessor and as Head of Global Environmental Risk Assessment (ERA) and Compliance. Richard is a technical expert in Environmental Risk Assessment (ERA), specializing in pharmaceuticals and general chemicals. He is fully conversant with the technical ERA requirements under REACH and EMA. He has represented AZ and national and EU pharmaceutical trade associations on many occasions in presenting industry views on developing regulatory ERA policy and guidelines. He has been a member of several ECETOC and OECD taskforces and participated in SETAC Pellston and DIA workshops and seminars on pharmaceuticals in the environment and ERA of pharmaceuticals. Richard has acted as project manager for many clients, helping to define protocols and manage delivery of studies to agreed timelines, including bespoke studies for difficult substances and suspected endocrine disruptors, several of which involved interactions with regulatory agencies to agree the design of studies. Dr. Lennart Weltje, Senior Regulatory Scientist, BASF SE, Crop Protection Ecotoxicology, Germany Lennart Weltje is a senior regulatory ecotoxicologist at BASF Crop Protection in Limburgerhof, Germany. Lennart holds a BSc and MSc in Biology (Utrecht University, The Netherlands) and a PhD in Ecotoxicology and Environmental Chemistry (Delft University, The Netherlands). From 1993 to 1995, he was employed as soil ecotoxicologist at the National Institute for Public Health and the Environment (RIVM, Bilthoven, The Netherlands) working on mixture toxicity. In 2001 he received a 2-year EU Marie-Curie postdoc fellowship to work on endocrine disruption in freshwater invertebrates at the International Graduate School in Zittau, Germany. In 2004 he started working for BASF, conducting aquatic risk assessments for plant protection products and biocides. Other topics he is involved with include endocrine disruption, mixture toxicity, sediment and aquatic invertebrates. Lennart is an active member of the endocrine disruption expert groups of the European Crop Protection Association, ECETOC and the SETAC Advisory Group on Endocrine Disruptor Testing and Risk Assessment and author of about 40 peer-reviewed papers. 11
13 Dr James Wheeler, Dow AgroSciences James is currently a Regulatory Ecotoxicologist working for Dow AgroSciences based in Abingdon, UK. Previous to that he worked, in a similar role, at Syngenta subsequent to completing a PhD at Royal Holloway University of London. He has broad interests based around ecotoxicological testing and environmental risk assessment for plant protection products. In addition to implementing the 3Rs into chemical safety assessment. James is a member of several scientific advisory groups. Currently these include the following: The OECD Endocrine Disruptor Testing and Assessment Task Force, OECD Validation Management Group for ecotoxicology, Ecotoxicology Team member for the National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs) and various industry association working groups. He has published over 50 research papers, review articles and book chapters. Professor Martin Wilks, Director of the Swiss Centre for Applied Human Toxicology, University of Basel Martin Wilks has been the founding director of the Swiss Centre for Applied Human Toxicology (SCAHT) since 2009 and Adjunct Professor at the Medical Faculty of the University of Geneva since Supported by the Swiss Confederation and the universities of Basel, Geneva and Lausanne, the SCAHT is dedicated to research, education and regulatory services in human toxicology and health risk assessment. Professor Wilks research and professional interests include clinical toxicology, toxico-epidemiology and risk assessment of chemical exposures. He obtained a doctorate in medicine in 1986 following his medical studies and internship at the Medical School Hannover (Germany). After completing a Ph.D. in toxicology at the University of Surrey (UK) in 1990 he worked as a medical toxicologist in the national health service and the chemical industry in the UK and Switzerland. He is a EUROTOX Registered Toxicologist and Fellow of the Royal College of Physicians of Edinburgh. He is President-elect of the European Association of Poison Control Centres and Clinical Toxicologists (EAPCCT) and Executive Committee member and Chairman of the Education Sub-Committee of EUROTOX, a Board member of the Swiss Society of Toxicology and Chairman of its Registration Committee. Professor Wilks is currently a member of the Committee for the Assessment of Poisonings at the German Federal Institute for Risk Assessment, and the Scientific Advisory Board of the Institutes for Medical NBC Protection, Medical Academy of the German Army. Dr Stewart Owen, AstraZeneca Stewart leads the AstraZeneca research into environmental effects of pharmaceuticals. This presentation will highlight recent progress with academic collaborations that he has developed over 10 years with AstraZeneca. He has 20 years postdoctoral experience and has interests in animal welfare leading the global AstraZeneca approach to 3Rs. 12
14 Prof Mark Cronin, Liverpool John Moores University Mark Cronin is Professor of Predictive Toxicology at Liverpool John Moores University. He has over 25 years expertise in the application of in silico approaches to predict the toxicity and fate of chemicals. Research in recent years has centred on the application of these alternatives for product development and regulatory risk assessment. Current research includes the application of chemical grouping and read-across to assess human health and environmental endpoints, in particular the linking of the Adverse Outcome Pathways (AOPs) to category formation. 13
15 NOTES 14
16 NOTES 15
Toxicology for the future research, development and education for chemical safety Welcome!
Toxicology for the future research, development and education for chemical safety Welcome! Ulla Stenius, Professor, Head of IMM, Professor, ERT, Programme Director Institute of Environmental Medicine,
More information2017 PROGRAM Hands-On Training
- FORMAT - - REGISTRATION FEE - 2 days training From Thursday morning to Friday evening 590 euros* without VAT Lectures Thursday morning Laboratory practices Rest of the time Training certificate can be
More informationMolecular Mechanisms of Food Contaminants Toxicity
Molecular Mechanisms of Food Contaminants Toxicity Course Leader: Joseph Rafter Department of Medical Nutrition, Karolinska Institutet, Stockholm, Sweden 09.00 09.15 Introduction Joseph Rafter, Professor,
More informationEuropean Advanced Risk Assessors Accredited Training Programme for Highly Qualified Toxicology Experts. General Project Overview
European Advanced Risk Assessors Accredited Training Programme for Highly Qualified Toxicology Experts General Project Overview What is TRISK? TRISK, is the acronym or short name for the project European
More informationSpeakers Title & Biography
Speakers Title & Biography Dr. Janice M. Soreth Deputy Director, FDA Europe Office/CDER, Liaison to EMA Dr. Soreth 20-year agency veteran with unparalleled experience, including serving as CDER's director
More informationWorkshop report: Pathways-based approaches across the biosciences: Towards application in practice
Workshop report: Pathways-based approaches across the biosciences: Towards application in practice Workshop: 28 April 2016 Report published: 29 July 2016 Natalie Burden NC3Rs Fiona Sewell NC3Rs Ian Kimber
More informationJOINT FAO/WHO FOOD STANDARDS PROGRAMME CODEX COMMITTEE ON PESTICIDE RESIDUES 50 th Session Haikou, P.R. China, 9-14 April 2018
JOINT FAO/WHO FOOD STANDARDS PROGRAMME CODEX COMMITTEE ON PESTICIDE RESIDUES 50 th Session Haikou, P.R. China, 9-14 April 2018 CRD18 ORIGINAL LANGUAGE Introduction Discussion Paper on the Uniform Risk
More information3 rd International Conference Endocrine Disruptors
3 rd International Conference Endocrine Disruptors Hot Topics The Commission s Proposal for the Criteria Testing Strategy for the Protection of Public Health Environmental Hazard and Risk Assessment Status
More informationThe application of new approaches in toxicology and ecotoxicology to risk assessment
ANNUAL TECHNICAL MEETING: YOUNG SCIENTIST EVENT Programme The application of new approaches in toxicology and ecotoxicology to risk assessment Poster session and cocktail reception 9 June 2009 17.00-19.00
More informationImmunotoxicology Technical Committee (ITC) HESI Assembly of Members January 19, 2009
Immunotoxicology Technical Committee (ITC) HESI Assembly of Members January 19, 2009 Committee Leadership Dr. Ellen Evans (Schering-Plough Research Institute), Chair Dr. Tom Kawabata (Pfizer Inc.), Vice
More informationILSI AGRICULTURAL CHEMICAL SAFETY ASSESSMENT (ACSA) PROJECT: A TIERED TESTING APPROACH. November 18, 2005
ILSI AGRICULTURAL CHEMICAL SAFETY ASSESSMENT (ACSA) PROJECT: A TIERED TESTING APPROACH Ann Blacker, PhD, DABT Head of Regulatory Toxicology Bayer CropScience November 18, 2005 HESI ACSA Technical Committee
More information1. Three Rs policy and investment
Activities undertaken under Article 47 of Directive 2010/63/EU on the protection of animals used for scientific purposes to contribute to the development, validation and promotion of alternative approaches,
More informationAddressing challenges in Drug Development and Quality Control with innovative solutions
Addressing challenges in Drug Development and Quality Control with innovative solutions SYNOPSIS 16 May 2013, 9:30 am 3:00 pm Gd. Titan Centre (Theater Room) This seminar is designed for scientists in
More informationEU MILESTONES ON ENDOCRINE DISRUPTING CHEMICALS (EDCS): OFFICIAL COMMITMENTS AND LEGISLATIVE ACTION ON EDCS IN THE EU
EU MILESTONES ON ENDOCRINE DISRUPTING CHEMICALS (EDCS): OFFICIAL COMMITMENTS AND LEGISLATIVE ACTION ON EDCS IN THE EU January 2014 October 1998 - the European Parliament adopted a Resolution calling upon
More informationHARMONISING ENVIRONMENTAL RISK ASSESSMENTS OF PESTICIDES
HARMONISING ENVIRONMENTAL RISK ASSESSMENTS OF PESTICIDES OECD DEVELOPMENT OF TEST GUIDELINES AND METHODOLOGIES EFSA Scientific Conference on ERA of pesticides Parma, 15-16 November 2016 OECD Secretariat
More informationMain achievements & Progress in Gianni Dal Negro, GlaxoSmithKline Industry Co-Chair EPAA Steering Committee
Main achievements & Progress in 2011 Gianni Dal Negro, GlaxoSmithKline Industry Co-Chair EPAA Steering Committee Overview of EPAA activities in 2011 Focus on Integrated Testing Strategies (annual theme)
More informationHigher National Diploma Biomedical Science
BMS is committed to developing scientists for the betterment of our country Higher National Diploma Biomedical Science leading to final year of BSc (Hons) Biomedical Science Committed to supporting students
More informationTHE ROLE OF IMAGING IN DRUG DISCOVERY, DRUG DEVELOPMENT AND IN CLINICAL STUDIES
THE ROLE OF IMAGING IN DRUG DISCOVERY, DRUG DEVELOPMENT AND IN CLINICAL STUDIES THURSDAY, 8 MARCH 2018 TRINITY HALL, TRINITY LANE, CAMBRIDGE, CB2 1TJ LEARNING OBJECTIVES TO UNDERSTAND THE ROLE FOR USING
More informationGuidance Document for the Implementation of the Hazard-based Criteria to Identify Endocrine Disruptors
Guidance Document for the Implementation of the Hazard-based Criteria to Identify Endocrine Disruptors Dr. José V. Tarazona Head Pesticides Unit EFSA Advisory Forum, June 2017 CONTENT 1. Background 2.
More informationBioscientists Do you have the Bayer Spirit?
CropScience HealthCare MaterialScience Business Services Industry Services Technology Services www.mybayerjob.com Bioscientists Do you have the Bayer Spirit? Research and Development, Screening, Toxicology,
More informationMissouri Regional Life Sciences Summit March 9, 2010 The Institute for Advancing Medical Innovation Stepping into the future of drug discovery, delivery and biomedical engineering G. Sitta Sittampalam,
More informationDosing for Controlled Exposure (DoCE): Dosing strategies for characterising in vitro dose-responses with increased relevance for in vivo extrapolation
Dosing for Controlled Exposure (DoCE): Dosing strategies for characterising in vitro dose-responses with increased relevance for in vivo extrapolation Background Chemical safety assessments continue to
More informationSupplementary exam work (Number, form, scope) Courses (type of teaching) Contact time. Winter semester
READING VERSION OF MODULE DESCRIPTIONS The module descriptions are not part of the Regulations; they are integrated into the First Amendment to the Module Catalog. IEW-M1.1 Principles in Toxicology Number
More informationSubcommittee on Distinguishing Adverse from Non-Adverse and Adaptive Effects
Subcommittee on Distinguishing Adverse from Non-Adverse and Adaptive Effects DOUGLAS A. KELLER, PhD (sanofi-aventis US) Subcommittee Co-Chair HESI Annual Meeting Reston, VA May 13, 2010 1 The issue Advances
More informationOMICS Journals are welcoming Submissions
OMICS Journals are welcoming Submissions OMICS International welcomes submissions that are original and technically so as to serve both the developing world and developed countries in the best possible
More informationDISCOVER OUR SEGMENT REGULATORY SCIENCE
DISCOVER OUR SEGMENT REGULATORY SCIENCE Our focus In the demanding regulatory environment of the EU, expert knowledge is essential to gaining approval for substances and products. That is why the scientific
More informationRecent years have witnessed an expansion in the disciplines encompassing drug
Course overview Recent years have witnessed an expansion in the disciplines encompassing drug discovery outside the pharmaceutical industry. This is most notable with a significant number of Universities
More informationIs the grass greener on the other side.? Academia to Industry Stephen B. Helliwell
Is the grass greener on the other side.? Academia to Industry Stephen B. Helliwell Senior Investigator, Novartis Institutes for BioMedical Research Is the grass greener? http://eatrio.net/2013/04/portuguese-idioms-joao-sem-braco.html
More informationTRIANNI Media Kit MEDIA CONTACT CORPORATE HEADQUARTERS. Trianni, Inc. San Francisco, CA
TRIANNI Media Kit CORPORATE HEADQUARTERS Trianni, Inc. San Francisco, CA Telephone: 1.866.374.9314 MEDIA CONTACT Mandy Boyd Director of Marketing @Trianni_mAb Website: Trianni.com TECHNOLOGY LEADERSHIP
More informationKey Aspects of Non-Clinical Pharmacology and Pharmacokinetics in the Evaluation of Safety
Safeguarding public health Key Aspects of Non-Clinical Pharmacology and Pharmacokinetics in the Evaluation of Safety David R Jones (david.jones@mhra.gsi.gov.uk) Expert Pharmacotoxicologist, Medicines and
More informationHazard, risk and the need for a scientific approach - criteria and weight of evidence for ecotoxicology assessments
Hazard, risk and the need for a scientific approach - criteria and weight of evidence for ecotoxicology assessments James Wheeler October 2012 Outline Background Proposed regulatory approaches in the EU
More informationSupplementary exam work (Number, form, scope) Courses (type of teaching) Contact time. Winter semester
IEW-M1.1 Principles in Toxicology Number of credit points (CP): 12 Introduction to general toxicology Foundations of toxicokinetics (ADME: absorption, distribution, metabolism, and excretion) Foundations
More informationSubmission to the House of Lords European Union Commission's White Paper "Strategy for a future Chemicals Policy"
Document 19/01 Submission to the House of Lords European Union Commission's White Paper "Strategy for a future Chemicals Policy" This is the Royal Society s response to the call for evidence by the House
More informationTemple of pharma - Speciality Chemicals Magazine
Page 1 of 5 Fine Chemicals Temple of pharma Dr Magid Abou-Gharbia will be bringing the insights from a distinguished career to a key panel discussion at Chemspec USA. We caught up with him at Temple University
More informationTranslational Research
Translational Research Paddy Johnston Chair, MRC Translational Research Overview Group October 2012 Translational Research Strategy and its delivery To accelerate patient benefit and increase economic
More informationSupport of refinement by the NC3Rs: Experiences and recommendations. Mark Prescott, PhD BfR-Forum, 13 December 2011
Support of refinement by the NC3Rs: Experiences and recommendations Mark Prescott, PhD BfR-Forum, 13 December 2011 The NC3Rs Independent, scientific organisation Established by UK Government in 2004 Use
More informationDIE AKADEMIE FRESENIUS
DIE AKADEMIE FRESENIUS Where Experts Meet! 8 th International Fresenius Conference Endocrine Disruptors 29 and 30 November 2017 in Cologne/Germany Highlights Regulatory Developments and socio-political
More informationMASTER S DEGREE IN BIOTECHNOLOGY AND MEDICAL BIOLOGY. Faculty of Medicine and Surgery
MASTER S DEGREE IN BIOTECHNOLOGY AND MEDICAL BIOLOGY Faculty of Medicine and Surgery PRESENTATION This 2-Year Master s Degree in Biotechnology and Medical Biology bridges theoretical knowledge to hands-on
More informationMaximizing opportunities towards achieving clinical success D R U G D I S C O V E R Y. Report Price Publication date
F o r a c l e a r e r m a r k e t p e r s p e c t i v e Early Stage Drug Safety Strategies & Risk Management Maximizing opportunities towards achieving clinical success D R U G D I S C O V E R Y Report
More informationJRC Summer School 2019: Non-Animal Approaches in Science
Draft Programme JRC Summer School 2019: Non-Animal Approaches in Science Challenges & Future Directions JRC Ispra 21-24 May 2019 @EU_ScienceHub #ECVAM The European Commission s science and knowledge service
More informationENVIRONMENTAL REGULATIONS AND STANDARD SETTING Environmental Quality Standards - P. D. Kalabokas, M.N. Christolis and N.C.
ENVIRONMENTAL QUALITY STANDARDS P. D. Kalabokas Research Centre for Atmospheric Physics and Climatology, Academy of Athens, Greece M.N. National Technical University of Athens, Chemical Engineering Dept.,
More information4 th ESPT SUMMER SCHOOL
4 th ESPT SUMMER SCHOOL PRECISION MEDICINE AND PERSONALISED HEALTH September 24-27, 2018 Geneva, Switzerland Dear Colleagues and Friends, It is a great pleasure and honour to invite you to the 4th ESPT
More informationDeputy Director General of Enterprise and Industry DG. Global Cooperation on alternatives (3Rs) to animal testing
Ref. Ares(2012)1356871-16/11/2012 SPEECH Antti PELTOMÄKI Deputy Director General of Enterprise and Industry DG Opening speech for the 8 th EPAA Annual Conference Global Cooperation on alternatives (3Rs)
More informationBiological & Pharmaceutical Sciences July 12-13, 2019 Yokohama, Japan
conferenceseries.com 2 nd International Conference on Biological & Pharmaceutical Sciences July 12-13, 2019 Yokohama, Japan Theme: Evolution in Science is Inevitable - Exploring Pharma & Life Sciences
More informationAdvanced Technologies in Diabetes Research and Therapy
Advanced Technologies in Diabetes Research and Therapy About Conference It is an incredible delight and a respect to stretch out our warm welcome to go to the Global Experts Meet on Advanced Technologies
More informationFUTURE MEANS CREATIVITY
START-UP & ACADEMICS THEORY & PRACTICE IN DRUG DEVELOPMENT 1 EARLY PHASE DRUG DEVELOPMENT COURSE MAY 9 TH 2017 - ANTWERP FUTURE MEANS CREATIVITY VENUE: LINDNER HOTEL LANGE KIEVITSTRAAT 125 BE-2018 ANTWERP,
More informationUsing 21 st Century Science for Risk-related evaluations: An Overview of the NAS Risk21 Report
Using 21 st Century Science for Risk-related evaluations: An Overview of the NAS Risk21 Report Committee on Incorporating 21st Century Science into Risk-Based Evaluations Board on Environmental Studies
More informationMSc in Management of Bioeconomy, Innovation and Governance
MSc in Management of Bioeconomy, Innovation and Governance A new postgraduate opportunity www.genomicsnetwork.ac.uk/innogen/studyhere/mscbig Take a lead role in the bioeconomy The Masters in Management
More informationStatistical Design Space Development from Design of Experiment to granules Expert of Solids Certification, Seminar 4 April 24 to 25, 2012
Statistical Design Space Development from Design of Experiment to granules Expert of Solids Certification, Seminar 4 April 24 to 25, 2012 Expert of Solids and Master of Solids certificated by Hüttlin GmbH
More informationsignificant concerns no or very low predictive power
Your feedback Citizens concerns should be considered How to ensure ethical concerns are harnessed to drive change? Don t separate Non-animal and animal approaches they are integrated Avoid overstating
More informationCENTER FOR BIOTECHNOLOGY
CENTER FOR BIOTECHNOLOGY Keith A. McGee, Ph.D., Program Director Math and Science Building, 3 rd Floor 1000 ASU Drive #870 Phone: 601-877-6198 FAX: 601-877-2328 Degree Offered Required Admission Test M.
More informationMSc in Food Biotechnology
MSc in Food Biotechnology Awarding Institution: The University of Reading Teaching Institution: The University of Reading Faculty of Life Sciences Programme length: 12 months For students entering in 2004
More informationA Global CRO STRONGER TOGETHER
A Global CRO STRONGER TOGETHER About us Unique Service Offering the first agrochemical CRO to offer a truly global service Part of the Eurofins Scientific Group of companies, Eurofins Agroscience Services
More informationECO-PHARMACO- STEWARDSHIP (EPS) PILLAR 1 - RESEARCH & DEVELOPMENT: INTELLIGENCE-LED ASSESSMENT OF PHARMACEUTICALS IN THE ENVIRONMENT (ipie)
ECO-PHARMACO- STEWARDSHIP (EPS) PILLAR 1 - RESEARCH & DEVELOPMENT: INTELLIGENCE-LED ASSESSMENT OF PHARMACEUTICALS IN THE ENVIRONMENT (ipie) PILLAR 1 - RESEARCH & DEVELOPMENT: INTELLIGENCE-LED ASSESSMENT
More informationNMI Natural and Medical Sciences Institute at the University of Tübingen
NMI Natural and Medical Sciences Institute at the University of Tübingen Markwiesenstrasse 55, 72770 Reutlingen, Germany GPS-Coordinate: 48 29 38.24 N 9 08 02.73 O AGENDA Get updated about latest developments
More informationAlternative (Non-animal) Methods for Chemicals Testing: Current Status and Future Prospects
Alternative (Non-animal) Methods for Chemicals Testing: Current Status and Future Prospects A Report prepared by ECVAM and the ECVAM Working Group on Chemicals Edited by Andrew Worth and Michael Balls
More informationStatistical Design Space Development from Design of Experiment to granules Expert of Solids Certification Seminar March 11 to 12, 2014
Statistical Design Space Development from Design of Experiment to granules Expert of Solids Certification Seminar March 11 to 12, 2014 Expert of Solids and Master of Solids certificated by Hüttlin GmbH
More informationCURRICULUM VITAE DONALD MACKAY. Professor Emeritus Environmental and Resource Studies,
CURRICULUM VITAE DONALD MACKAY Professor Emeritus Environmental and Resource Studies, Director Emeritus Centre for Environmental Modelling and Chemistry, Trent University Peterborough, Ontario, Canada
More informationAddressing Complex Challenges Posed by Hazardous Substances
Addressing Complex Challenges Posed by Hazardous Substances William A. Suk, Ph.D., M.P.H. Director, Superfund Research Program Chief, Hazardous Substances Research Branch Division of Extramural Research
More informationMEDICAL DEVICES PROGRAMME
MEDICAL DEVICES PROGRAMME 3-4 October 2017 Medical Devices Symposium, updated 29August 2017, external Page 1 Working Party Margareth Jorvid LSM Group, Sweden (Chair) Michael Kipping MHRA, UK Janine Jamieson
More informationAntibody Discovery at Evotec
Antibody Discovery at Evotec - Overview - Evotec Antibodies Adding value to our partners research Innovative and flexible solutions from target ID to pre-clinical candidate The people A wide therapeutic
More informationAssuring data integrity; best practice
Assuring data integrity; best practice Royal Society of Chemistry, Burlington House, Piccadilly, London W1J 0BA Thursday 16th March 2017 Data integrity is receiving much attention in the pharmaceutical
More informationEndocrine disruptors: EURL ECVAM activities related to validation
The European Commission s science and knowledge service Joint Research Centre Endocrine disruptors: EURL ECVAM activities related to validation Elise Grignard 1 EU legislative background on endocrine disruptors
More informationA Strategy for Reducing Animal Use in the U.S. EPA's Endocrine Disruption Screening Program
A Strategy for Reducing Animal Use in the U.S. EPA's Endocrine Disruption Screening Program Catherine Willett, PhD Science Policy Advisor Patricia Bishop, M.S. Research Associate Kristie Sullivan, MPH
More informationRoyal Society of Chemistry. Expert Panel on Endocrine Disrupter Low Dose Effects. RSC London 4 th June 2014
Introduction Royal Society of Chemistry Expert Panel on Endocrine Disrupter Low Dose Effects RSC London 4 th June 2014 The RSC held a Workshop on Low Doses Effects of Endocrine Disrupters (ED) on June
More informationGet started with HTRF
Get started with HTRF A training program for academic researchers and students François Degorce, Fabienne Charrier- Savournin Context and objectives Who never used an ELISA or a Western Blot in a biology
More informationSafeSciMET. European Modular Education and Training Programme in Safety Sciences for Medicines
SafeSciMET European Modular Education and Training Programme in Safety Sciences for Medicines What patients need What Europe needs Rapid exploitation of insights in disease mechanisms for introduction
More informationBridging between ecology, ecotoxicology and ecosystems services
Bridging between ecology, ecotoxicology and ecosystems services Gertie Arts, Elisabeth Maria Gross, Sabine Elisabeth Apitz, Lorraine Maltby May 9, 11:05-16:00, Meeting Studio 311 & 312 Ecosystems provide
More informationPage 1 of 5 Message from the Director: As the summer kicks off, many of us will renew our focus on research and scholarship. Towards this goal, we draw your attention to a several upcoming events and opportunities
More informationNational Academic Reference Standards (NARS) Pharmacy. January st Edition
National Academic Reference Standards (NARS) Pharmacy January 2009 1 st Edition Table of Contents Introduction to Pharmacy Education 1 National Academic Reference Standards 3 Curriculum Structure 10 Glossary
More informationEnvigo Corporate & Industry Overview. Rutgers University
Envigo Corporate & Industry Overview Rutgers University Joseph Bedford, Ph.D. Corporate Vice President, Strategic Marketing November 15, 2016 envigo.com 1 Who we are Envigo is a global contract research
More informationThe SNEC Day November 25, 2014 Palmstedtsalen, Chalmers
The SNEC Day 2014 November 25, 2014 Palmstedtsalen, Chalmers Sustainable Nuclear Education, or how to maintain competences and knowledge in the nuclear area when the economic, political, and societal conditions
More informationKEYNOTE SPEAKER. Professional Preparation
KEYNOTE SPEAKER Gursimran Singh Walia Associate Professor of Computer Science QBB 258 A17; Department of Computer Science North Dakota State University Fargo, North Dakota 58105 gursimran.walia@ndsu.edu;
More informationINTERNATIONAL PROGRAMME ON CHEMICAL SAFETY Project on the Harmonization of Approaches to the Assessment of Risk from Exposure to Chemicals
INTERNATIONAL PROGRAMME ON CHEMICAL SAFETY Project on the Harmonization of Approaches to the Assessment of Risk from Exposure to Chemicals WHO/IPCS Scoping Meeting for the Development of Guidance for Immunotoxicity
More informationSETAC AP The 11 th Society of Environmental Toxicology and Chemistry Asia-Pacific. September 16(Sun) ~ 19(Wed), 2018 / EXCO, Daegu
Dear Sponsor/Exhibitor The Society of Environmental Toxicology and Chemistry and its worldwide membership invite you to be a sponsor and/or an exhibitor at our congress, September 16-19, 2018 at the renowned
More informationPolicy and Procedure for Professorial and Managerial and Specialist Grade 10 Salaries
Policy and Procedure for Professorial and Managerial and Specialist Grade 10 Salaries Human Resources Department Lead Director: Director of Human Resources Date ratified by Council: 26 April 2012 Policy
More informationWhat is biomedical science?
What is biomedical science? Biomedical science is the science at the heart of healthcare Everyone will use the services of biomedical scientists more than once during their life Samples taken by doctors
More informationWHAT HAPPENS AFTER A PHD?
WHAT HAPPENS AFTER A PHD? MY BIOGRAPHICAL SKETCH Sandviks gård 29 August 2013 Pernilla Eliasson 20130828 Outline Postdoc in Utrecht Leaving academia and work at a Biotech company Working in the Pharma
More informationInternational Conference of the Korean Society for Molecular and Cellular Biology
KSMCB The 26 th International Conference of the Korean Society for Molecular and Cellular Biology October 21 (Tue) ~ 23 (Thu), 2014 Seminar : Grand Ballroom (1F) Exhibition & Poster Presentation : Hall
More informationPIONEERING WORLD-CLASS DRUG DISCOVERY IN AFRICA
PIONEERING WORLD-CLASS DRUG DISCOVERY IN AFRICA MISSION & VISION Prof. Kelly Chibale H3D Director Vision To be the leading organisation for integrated drug discovery and development on the African continent.
More informationAgreed with W. Cornell Graduate Program and Tri-I
Drug Development Course From Molecule to Prescription Weill Cornell Graduate School - Tri-Institutional Therapeutics Discovery Institute ABOUT THIS COURSE This course has been designed in collaboration
More informationDrug Discovery Toxicology Webinar
1 2012 2013 Vertex Pharmaceuticals Incorporated Drug Discovery Toxicology Webinar Brandon Jeffy, Ph.D., DABT Toxicologist, Discovery and Investigative Fellow Vertex Pharmaceuticals, San Diego Site 05 APR
More informationELRIG EVENTS
ELRIG EVENTS 2019 www.twitter.com/@elrig_uk www.linkedin.com/company/elrig www.elrig.org www.facebook.com/elriguk ELRIG Events 2019 Welcome to ELRIG s 2019 events brochure! In 2019 we will once again host
More informationUpdate of the WHO/IPCS Mode of Action Framework
Update of the WHO/IPCS Mode of Action Framework ECETOC/WHO/IPCS Mode of Action Workshop Vienna, February 21 st 22 nd, 2013 Presented by: M.E. (Bette) Meek University of Ottawa bmeek@uottawa.ca Outline
More informationDiversifying Income Streams
#PARNDiversify Spring Conference Diversifying Income Streams 12 May Royal College of Nursing London Contents About the Conference Programme for the Day Speakers & Topics PARN Events & Research 2016 Presentation
More informationANIMAL SCIENCE COURSE PLANNING
ANIMAL SCIENCE COURSE PLANNING Animal Science major offers an opportunity to apply animal biology, physiology, biochemistry, molecular biology and other life sciences to the study of animal breeding and
More information4 th ESPT SUMMER SCHOOL
4 th ESPT SUMMER SCHOOL SUPPORTED BY SPHN PRECISION MEDICINE AND PERSONALISED HEALTH September 24-27, 2018 Geneva, Switzerland Dear Colleagues and Friends, It is a great pleasure and honour to invite you
More informationProgress and Future Directions in Integrated Systems Toxicology. Mary McBride Agilent Technologies
Progress and Future Directions in Integrated Systems Toxicology Mary McBride Agilent Technologies 1 Toxicity testing tools of the late 20 th century Patchwork approach to testing dates back to the 1930
More informationTHE ANSWERS YOU NEED ARE ALL RIGHT HERE
Battelle Toxicology THE ANSWERS YOU NEED ARE ALL RIGHT HERE Pre-Clinical Toxicology Industrial Toxicology Environmental Exposure Studies PUT THE POWER OF BATTELLE TO WORK FOR YOU Whether you re trying
More informationHighlights from EPAA projects 2: Acute Toxicity. Thomas Holmes MSc ERT Exponent International Limited
Highlights from EPAA projects 2: Acute Toxicity Thomas Holmes MSc ERT Exponent International Limited Group Members International involvement for international outcomes Regulator involvement to promote
More informationThe OECD activities on biocides and IATA
The OECD activities on biocides and IATA Sylvie Poret & Joop de Knecht OECD Secretariat 18-20 November 2013, Vienna Presentation Outline What is OECD? The OECD Biocides Programme The OECD framework for
More informationWhy do clinicians love 3+3? How do we help them de-love it? How to properly model late onset toxicity?
Why do clinicians love 3+3? How do we help them de-love it? How to properly model late onset toxicity? How to use big data in drug development and dose selection? How to design combination dose-finding
More informationEURL ECVAM. A broader role for greater impact. Maurice Whelan. Head of Systems Toxicology Unit and EURL ECVAM
EURL ECVAM A broader role for greater impact Maurice Whelan Head of Systems Toxicology Unit and EURL ECVAM Institute for Health and Consumer Protection DG Joint Research Centre Meeting of the EP Intergroup
More informationSTUDIES TO EVALUATE THE SAFETY OF RESIDUES OF VETERINARY DRUGS IN HUMAN FOOD: GENERAL APPROACH TO TESTING
VICH GL33 (SAFETY: GENERAL APPROACH) October 2002 For implementation at Step 7 - Final STUDIES TO EVALUATE THE SAFETY OF RESIDUES OF VETERINARY DRUGS IN HUMAN FOOD: GENERAL APPROACH TO TESTING Recommended
More informationBiology Registration Newsletter for Fall 2018 Courses
Biology Registration Newsletter for Fall 2018 Courses This newsletter contains the information most relevant for registration for Fall 2018 courses. A detailed description of policies, graduation requirements,
More informationThe Role of Chemistry in Adverse Outcome Pathways. Paul Russell & Steve Gutsell Safety and Environmental Assurance Centre, Unilever April 2013
The Role of Chemistry in Adverse Outcome Pathways Paul Russell & Steve Gutsell Safety and Environmental Assurance Centre, Unilever April 2013 Contents Background Risk Assessment in FMCG industry Drivers
More informationInternational Conference on Veterinary & Animal Sciences
International Conference on Veterinary & Animal Sciences Gavin Conferences invites participants from all over the world to attend International Conference on Veterinary & Animal Sciences. Veterinary 2019
More informationTHE GADEN MEMORIAL LECTURE
ELMER L. GADEN JR., widely known as the father of biochemical engineering, received all of his degrees from Columbia. Shortly after receiving his doctorate in 1949, he became a faculty member and remained
More informationPRESENTATION DATA. Track: Exhibitor Tutorial Session: Exhibitor Tutorial (12:30 PM 1:45 PM) Monday, February 5, :30 PM 1:45 PM Room: Room 5A
Session: Exhibitor Tutorial (12:30 PM 1:45 PM) Monday, February 5, 2018 12:30 PM 1:45 PM Room: Room 5A The New Sound of Sample Management Development of new technologies and software to enable the use
More informationBiomedical Sciences Graduate Program
1 of 6 Graduate School 250 University Hall 230 North Oval Mall Columbus, OH 43210-1366 January 11, 2013 Phone (614) 292-6031 Fax (614) 292-3656 Jeff Parvin, Joanna Groden Co-Graduate Studies Chairs Biomedical
More information